Non–Small Cell Lung Cancer: Streamlining Turnaround Times in Biomarker Testing

Expert perspectives on improving turnaround times in genomic testing for lung cancer, covering strategies, challenges, and the significance of liquid biopsy in optimizing patient care.

Related Keywords

,Precision Medicine ,Biomarker Testing ,Small Cell Lung Cancer ,Streamlining Turnaround Times ,Nsclc ,Non Small Cell Lung Cancer ,Lung Cancer ,Genomic Testing ,Rings ,Next Generation Sequencing ,Liquid Biopsy ,Tissue Based Testing ,Ctdna ,Circulating Tumor Dna ,Reflex Testing ,Treatment Paradigm ,Patient Care ,